Ujfalusi A, Cseppentö A, Nagy E, Szabó J Z, Kovács P, Szentmiklósi A J
Department of Pharmacology, University Medical School of Debrecen, Hungary.
Life Sci. 1999;64(2):PL19-25. doi: 10.1016/s0024-3205(98)00547-5.
The effects of a 10-day i.p. treatment of rats with diazepam on responses to subtype selective adenosine receptor agonists were studied 3 h, 2 and 8 days after termination of diazepam treatment in isolated cardiovascular tissues possessing distinct adenosine receptors. After long-lasting diazepam exposure, the relaxation elicited by the specific A2A receptor agonist CGS 21680 was enhanced in rat main pulmonary arteries (a tissue containing A2A adenosine receptors). The increased sensitivity of A2A receptors observed 3 h and 2 days after withdrawal of diazepam was completely restored by the 8th day of the wash-out period. N6-cyclopentyladenosine (CPA)-induced suppression in mechanical activity of electrically stimulated rat atrial myocardium (a tissue containing A1 adenosine receptors) was not altered following diazepam treatment. In order to reveal the possible role of inhibition of membrane adenosine transport in the effects of diazepam (a moderate inhibitor of membrane adenosine transport), the action of a 10-day treatment with dipyridamole or S-(p-nitrobenzyl)-6-thioinosine (NBTI; prototypic adenosine uptake inhibitors) was also studied. Dipyridamole or NBTI treatment, like diazepam, increased the responsiveness of rat pulmonary artery to CGS 21680, but did not influence the cardiodepressive effect of CPA in electrically driven left atrial myocardium. The CGS 21680-induced relaxations were significantly antagonized by 10 nM ZM 241385 (a selective A2A adenosine receptor antagonist) in vessels of diazepam-treated rats. The relaxation responses to verapamil were unaltered in pulmonary arteries obtained from animals chronically treated with diazepam, dipyridamole or NBTI. These results suggest that chronic diazepam treatment is able to enhance the A2A adenosine receptor-mediated vascular functions, but does not modify the responses mediated via A1 receptors of rat myocardium, where nucleoside transport inhibitory sites of membrane are of a very low density. It is possible that sensitization of A2A adenosine receptor-mediated vasorelaxation is due to a long-lasting inhibition of membrane adenosine transporter during diazepam treatment.
在具有不同腺苷受体的离体心血管组织中,研究了大鼠腹腔注射地西泮10天对亚型选择性腺苷受体激动剂反应的影响,观察时间为地西泮治疗终止后的3小时、2天和8天。经过长时间的地西泮暴露后,特异性A2A受体激动剂CGS 21680在大鼠主肺动脉(一种含有A2A腺苷受体的组织)中引起的舒张作用增强。在撤用地西泮后3小时和2天观察到的A2A受体敏感性增加在洗脱期第8天时完全恢复。地西泮治疗后,N6-环戊基腺苷(CPA)对电刺激大鼠心房肌(一种含有A1腺苷受体的组织)机械活性的抑制作用未改变。为了揭示抑制膜腺苷转运在地西泮(一种中等强度的膜腺苷转运抑制剂)作用中的可能作用,还研究了双嘧达莫或S-(对硝基苄基)-6-硫代肌苷(NBTI;典型的腺苷摄取抑制剂)10天治疗的作用。双嘧达莫或NBTI治疗与地西泮一样,增加了大鼠肺动脉对CGS 21680的反应性,但不影响CPA对电驱动左心房肌的心脏抑制作用。在用地西泮治疗的大鼠血管中,10 nM ZM 241385(一种选择性A2A腺苷受体拮抗剂)显著拮抗了CGS 21680引起的舒张作用。从长期用地西泮、双嘧达莫或NBTI治疗的动物获得的肺动脉中,对维拉帕米的舒张反应未改变。这些结果表明,慢性地西泮治疗能够增强A2A腺苷受体介导的血管功能,但不改变大鼠心肌A1受体介导的反应,在大鼠心肌中膜核苷转运抑制位点的密度非常低。A2A腺苷受体介导的血管舒张致敏可能是由于地西泮治疗期间膜腺苷转运体的长期抑制。